Concepedia

Changping Wu

CW

Statistics

Publications

42

Citations

3.2K

H-Index

26

Active since

2006

Affiliations

Soochow University(Current)

The First People's Hospital of Changzhou

Harbin Medical University

Sun Yat-sen University Cancer Center

Third Affiliated Hospital of Harbin Medical University

Changping Wu is an author at Soochow University specializing in oncology, medicine, and molecular oncology.

Publications per year

2006–2021

42

Publications

42

Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer

Jin Li, Shukui Qin, Rui‐Hua Xu et al. · JAMA · 2018 · 404 citations · Full text

Medicine, Oncology, Pharmacology +17

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

Masatoshi Kudo, Guohong Han, Richard S. Finn et al. · Hepatology · 2014 · 347 citations

Pharmacy, Oncology, Pharmacology +14

PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor

Liangrong Shi, Lujun Chen, Changping Wu et al. · Clinical Cancer Research · 2016 · 310 citations · Full text

Medicine, Immunology, Oncology +17

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study

Jianming Xu, Tae Won Kim, Lin Shen et al. · Journal of Clinical Oncology · 2017 · 257 citations

Medicine, Oncology, Pharmacotherapy +9

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Shukui Qin, Li Qiu, Shanzhi Gu et al. · The Lancet. Gastroenterology & hepatology · 2021 · 254 citations

Medicine, Oncology, Pharmacotherapy +10

1–5 of 42